Literature DB >> 7743462

Platelet-activating factor antagonists.

M Koltai1, P G Braquet.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7743462     DOI： 10.1007/BF02802300

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  77 in total

1.  Pharmacological profile of TCV-309--a potent PAF antagonist.

Authors:  Z Terashita; M Takatani; K Nishikawa
Journal:  J Lipid Mediat       Date:  1992 Jun-Jul

2.  Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.

Authors:  J Nagaoka; K Harada; A Kimura; S Kobayashi; M Murakami; T Yoshimura; K Yamada; O Asano; K Katayama; I Yamatsu
Journal:  Arzneimittelforschung       Date:  1991-07

Review 3.  L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors.

Authors:  S B Hwang; M H Lam
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.

Authors:  F N Ko; S M Yu; I S Chen; H Ishii; Y L Chang; T F Huang; C M Teng
Journal:  Biochim Biophys Acta       Date:  1993-01-17

5.  Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

Authors:  R Rabinovici; T L Yue; M Farhat; E F Smith; K M Esser; M Slivjak; G Feuerstein
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

6.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

7.  Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and rats.

Authors:  H O Heuer; B Keller; K Urich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

8.  Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.

Authors:  T L Yue; R Rabinovici; M Farhat; G Feuerstein
Journal:  J Lipid Mediat       Date:  1991 Jan-Feb

9.  In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.

Authors:  A Etienne; F Hecquet; C Soulard; B Spinnewyn; F Clostre; P Braquet
Journal:  Agents Actions       Date:  1986-01

10.  PAF inhibitory activity of diketopiperazines: structure-activity relationships.

Authors:  N Shimazaki; I Shima; M Okamoto; K Yoshida; K Hemmi; M Hashimoto
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
View more
  2 in total

1.  Total synthesis of phomactin A.

Authors:  Yu Tang; Kevin P Cole; Grant S Buchanan; Gang Li; Richard P Hsung
Journal:  Org Lett       Date:  2009-04-02       Impact factor: 6.005

Review 2.  Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis; Constantinos A Demopoulos
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.